Table of Contents
<< Previous Issue | Jun 2006 (Vol: 2006, Issue: 72) | Next Issue >> |
- Section: Business Commentaries
-
Let Knowledge Flow
- Section: Cartoons
-
Ready Steady Bio
- Section: Deal Trackers
-
Diquafosol
- Section: Distribution & Marketing
-
Kos to Market SkyePharma’s Flutiform™
- Section: Features
-
Therapy Focus: Hypoxia-Selective Agents as Anticancer Drugs
-
Deal Making Spotlights on Big Pharma
-
Astellas Enters into Yet Another Agreement
-
Abraxis and AstraZeneca Exchange Agreements
- Section: General
-
IPOs: Still the Exit Strategy of Choice?
-
ExonHit Therapeutics SA
- Section: Licensing
-
Chelsea Augments its Pipeline
-
Immunomedics Relights its Therapeutic Potential
- Section: Mergers & Acquisitions
-
AstraZeneca to Acquire Cambridge Antibody Technology
- Section: Research & Development
-
Boehringer Ingelheim’s Bonanza Month